^
Contact us to learn more about
our Premium Content: News alerts, weekly reports and conference plannersDRUG:
dronabinol oral
i
Other names: BX-1, ECP002A, delta9-THC, THC, PP-001
Contact us to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Company:
Generic mfg.
Drug class:
Cannabinoid receptor agonist
Related drugs:
10d
DEMURE: Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial (clinicaltrials.gov)
P3, N=40, Not yet recruiting, Montefiore Medical Center | Trial completion date: Aug 2027 --> Dec 2027 | Initiation date: Jan 2026 --> May 2026 | Trial primary completion date: Aug 2027 --> Dec 2027
Trial completion date • Trial initiation date • Trial primary completion date
|
Epidiolex (cannabidiol) • dronabinol oral
17d
Tetrahydrocannabinol (THC) and Sleep (clinicaltrials.gov)
P1, N=18, Completed, Oregon Health and Science University | Active, not recruiting --> Completed | Trial completion date: Apr 2025 --> Dec 2025
Trial completion • Trial completion date
|
dronabinol oral
1m
Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults (clinicaltrials.gov)
P1, N=48, Recruiting, Food and Drug Administration (FDA) | Not yet recruiting --> Recruiting | Initiation date: Sep 2025 --> Dec 2025
Enrollment open • Trial initiation date
|
dronabinol oral
3ms
Synthetic THC And Blood Pressure (clinicaltrials.gov)
P2/3, N=50, Not yet recruiting, Mayo Clinic
New P2/3 trial
|
dronabinol oral
3ms
Sex Differences in Neurobehavioral Response to THC (clinicaltrials.gov)
P2, N=40, Not yet recruiting, Medical University of South Carolina
New P2 trial
|
dronabinol oral
4ms
PK/PD of Oral and Vaporized Delta-9-Tetrahydrocannabinol (THC) in Older Adults (clinicaltrials.gov)
P1, N=20, Recruiting, Yale University | Trial primary completion date: Aug 2025 --> Jun 2026 | Trial completion date: Aug 2025 --> Aug 2026
Trial completion date • Trial primary completion date
|
dronabinol oral
5ms
DEMURE: Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial (clinicaltrials.gov)
P3, N=40, Not yet recruiting, Montefiore Medical Center | Trial completion date: Apr 2027 --> Aug 2027 | Initiation date: Sep 2025 --> Jan 2026 | Trial primary completion date: Apr 2027 --> Aug 2027
Trial completion date • Trial initiation date • Trial primary completion date
|
Epidiolex (cannabidiol) • dronabinol oral
5ms
CRISP: Cannabinoids for the Reduction of Inflammation and Sickle Cell Related Pain (clinicaltrials.gov)
P2, N=60, Recruiting, Icahn School of Medicine at Mount Sinai | Trial completion date: Jun 2026 --> May 2027 | Trial primary completion date: Jun 2026 --> Apr 2027
Trial completion date • Trial primary completion date
|
IL4 (Interleukin 4)
|
dronabinol oral
5ms
Dronabinol As an Adjunct for Reducing Pain (DARP)-Texas Children's Hospital (clinicaltrials.gov)
P2, N=75, Not yet recruiting, Baylor College of Medicine | Initiation date: May 2025 --> Jan 2026 | Trial primary completion date: Dec 2027 --> Dec 2026
Trial initiation date • Trial primary completion date
|
dronabinol oral
5ms
Clinical Study to Evaluate the Effects of Oral Delta-9-tetrahydrocannabinol (Δ9-THC) With and Without Alcohol on Perception and Driving Performance in Healthy Adults (clinicaltrials.gov)
P1, N=48, Not yet recruiting, Food and Drug Administration (FDA)
New P1 trial
|
dronabinol oral
5ms
DROSA: DRonabinol Treatment of OSA (clinicaltrials.gov)
P1/2, N=120, Recruiting, VA Office of Research and Development | Not yet recruiting --> Recruiting
Enrollment open
|
dronabinol oral
6ms
DEMURE: Dronabinol and Epidiolex to Manage Uncontrolled Residual Symptoms of Buprenorphine Initiation Trial (clinicaltrials.gov)
P3, N=40, Not yet recruiting, Montefiore Medical Center
New P3 trial
|
Epidiolex (cannabidiol) • dronabinol oral
Share via
